Peer-reviewedCC BYJournal of human immunity
Higher serum sCD14 is an independent biomarker for porto-sinusoidal vascular disease risk in CVID
- 1, Paris,
Related
- Liver sinusoidal endothelial cells and laminin dictate cholangiocytes’ fate in chronic liver disease
- Vascularizing neurospheroids to probe vascular contributions to α-synuclein pathology in Parkinson's disease
- Circulating angiogenic T cells as potential immune-vascular biomarkers associated with disease activity in axial spondyloarthritis
- Alzheimer’s disease research must connect vascular molecular phenotypes with physiology
- Quantum Dot-Based Non-invasive Monitoring of Sinusoidal Endothelial Scavenger Function in Steatohepatitis
BibTeX
@article{delaval2026higher,
title = {{Higher serum sCD14 is an independent biomarker for porto-sinusoidal vascular disease risk in CVID}},
author = {Laure Delaval and Karim Dorgham and Jehane Fadlallah and Emilie Corvilain and Pierre-Emmanuel Rautou and Eric Oksenhendler and Claire Fieschi and Guy Gorochov and Marion Malphettes},
journal = {Journal of human immunity},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13674294},
note = {CC BY},
}
RIS
TY - JOUR
TI - Higher serum sCD14 is an independent biomarker for porto-sinusoidal vascular disease risk in CVID
AU - Laure Delaval
AU - Karim Dorgham
AU - Jehane Fadlallah
AU - Emilie Corvilain
AU - Pierre-Emmanuel Rautou
AU - Eric Oksenhendler
AU - Claire Fieschi
AU - Guy Gorochov
AU - Marion Malphettes
PY - 2026
DA - 2026/10/16
JO - Journal of human immunity
UR - https://europepmc.org/article/PMC/PMC13674294
SN - 3065-8993
ER -